Biocept's Liquid Biopsy Lung Cancer Target Selector Assay to be featured at World Conference on Lung Cancer
September 08, 2015 at 07:03 AM EDT
Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection ...